Home » Healthcare » Pharmaceuticals » Antipsoriatics Market

Antipsoriatics Market By Treatment Type (Topical Agents, Systemic Agents) By Biologics (TNF Inhibitors, IL Inhibitors, Topical Corticosteroids) By Patient Age Group (Adults, Pediatrics) – Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Summary
Table Of Content

Market Insights

The global demand for Antipsoriatics was valued at USD XX million in 2022 and is expected to reach USD XX Million in 2030, growing at a CAGR of 8.20% between 2023 and 2030.

Topical agents are in significant demand, and systemic agents are widely recognized as the market’s second largest group.
IL inhibitors are the fastest growing sector in the Antipsoriatics Market, while topical corticosteroids are another important sector in the Antipsoriatics Market.
The adults sector is the most prominent, but the Pediatrics sector is also significant.
The moderate to severe sector is the largest stakeholder, and the mild to moderate segment is also a significant player in the Antipsoriatics Market.
The bigger the market need for topical therapies, the greater the market demand for injectable medications.
The sector of generic pharmaceuticals has the highest CAGR, and branded medications are another component of the Antipsoriatics Market.
North America will account for 45% of the Antipsoriatics Market by 2022, with the Asia Pacific region expected to have the highest compound annual growth rate.
The rising prevalence of Psorasis fuels market expansion.
Potential Antipsoriatic Side Effects impede Market Growth

Executive Summary

Market Definition

The Antipsoriatics Market refers to the market for pharmaceutical medicines and therapies that are specifically developed to manage and treat psoriasis, a chronic skin ailment marked by red, inflammatory patches and silvery scales. These items may include topical creams, oral drugs, biologic therapy, and other interventions intended at lowering inflammation, regulating symptoms, and enhancing the quality of life for people with psoriasis. The antipsoriatics industry includes a variety of pharmaceutical businesses, healthcare providers, and research institutes aiming to create effective psoriasis therapies.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Overview

The global Antipsoriatics Market has been steadily growing in recent years and is predicted to grow at a 8.20% CAGR between 2023 and 2030. The market is anticipated to be worth USD XX million by 2030, up from USD XX million in 2022.

The Antipsoriatics Market is expanding rapidly and has enormous potential! Several factors are propelling this market, including the rising prevalence of psoriasis, which increases demand for effective therapies. Furthermore, people are becoming more aware of the available treatment alternatives, which is leading to a higher adoption rate.

However, there are several constraints that must be addressed. Medication costs might be prohibitively expensive for some patients, limiting their access to treatment. Furthermore, several antipsoriatic drugs may cause adverse effects, which may affect patient adherence and satisfaction.

Medical research and technology developments are opening the way for the creation of novel medicines and treatment approaches. Furthermore, the market has substantial growth potential in emerging economies, where psoriasis awareness is growing and healthcare infrastructure is becoming more important.

Segmentation by Treatment Type

Topical agents are in high demand in the Antipsoriatics Market. Topical treatments, such as ointments, creams, and gels, are often used to treat mild to moderate psoriasis and provide localized relief.
Systemic agents are commonly regarded as the second largest group.

Segmentation by Biologics

IL inhibitors are the fastest expanding sector in the Antipsoriatics Market. Because of their tailored approach to blocking specific cytokines implicated in the inflammatory response of psoriasis, IL inhibitors have gained substantial momentum in recent years.
Another key sector in the Antipsoriatics Market is topical corticosteroids.

Segmentation by Patient Age Group

The adults section is the most important. This is because psoriasis is more common in adults than in children. The majority of psoriasis research, development, and therapy options are directed toward adult sufferers.
The Pediatrics sector is another big market share holder.

Segmentation by Severity of Psoriasis

The moderate to severe sector is the largest shareholder. This is because individuals with moderate to severe psoriasis frequently require more intensive and systemic therapy choices to adequately control their illness, such as oral medicines, injectables, and biologics.
Another major sector in the Antipsoriatics Market is the mild to moderate segment.

Segmentation by Delivery method

The greater the market need for topical treatments. This is due to the fact that topical drugs provide a simple and non-invasive therapy option for psoriasis patients, particularly those with mild to moderate symptoms.
Injectable drugs are another section of the Antipsoriatics Market.

Segmentation by Branded Vs Generic Products

The generic medications segment has the highest CAGR (Compound Annual Growth Rate). This is because generic drugs are often less expensive and more widely available than branded medications.
Branded medications are another component in the Antipsoriatics Market.

Segmentation by Region

North America will account for 45% of the Antipsoriatics Market by 2022.
The Asia Pacific region is predicted to have the greatest compound annual growth rate in the Antipsoriatics Market.
The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Antipsoriatics.

North America is the largest region in the Antipsoriatics Market because to the high prevalence of psoriasis in this region. Psoriasis is a chronic skin illness that affects millions of people worldwide, with a high prevalence in North America. The increased knowledge and understanding of psoriasis, as well as the availability of improved healthcare facilities and treatment alternatives, all contribute to the growth of the Antipsoriatics Market in North America. Furthermore, the region’s strong research and development efforts, as well as favourable reimbursement regulations, help the market’s expansion in this region.

Asia Pacific has the largest growth rate in the Antipsoriatics Market, which can be attributed to the rising prevalence of psoriasis in the region. Psoriasis affects a large number of people throughout Asia Pacific, and awareness and diagnosis of the ailment are on the rise. As a result, there is a growing demand in the region for effective antipsoriatic drugs and treatment choices. Furthermore, growing healthcare infrastructure, rising disposable incomes, and increased access to healthcare services all contribute to the growth of the Asia Pacific Antipsoriatics Market. The region’s vast population and rising healthcare costs also contribute to the market’s rapid rise.

Key Highlights of the Report

The global Antipsoriatics Market is segmented by Treatment Type, Biologics, Patient Age Group, Severity of Psoriasis, Delivery method, randed Vs Generic Products and region. The segment of moderate to severe and topical therapies is the largest shareholder. Furthermore, generic drugs have the greatest CAGR, and IL inhibitors are the fastest growing sector in the Antipsoriatics Market. Also, topical agents are in high demand in the market, with North America leading the market growth.

The main drivers of the market include the rising prevalence of psoriasis, increased awareness about possible therapies, and advancements in medical research. Furthermore, the industry faces several hurdles, including high drug costs, potential side effects of antipsoriatic treatments, and limited access to treatment for some patients.

Nonetheless, North America is the largest region in the Antipsoriatics Market because to the high prevalence of psoriasis in this region. Millions of individuals throughout the world suffer from the chronic skin condition psoriasis, which is very common in North America. Furthermore, Asia Pacific has the highest growth rate in the Antipsoriatics Market, which can be ascribed to the increased prevalence of psoriasis in the region. Psoriasis affects a vast number of people throughout Asia Pacific, and awareness and diagnosis are increasing.

What Factors Are Fueling The Growth Of The Global Antipsoriatics Market?

The prevalence of psoriasis is increasing, producing a greater need for effective therapies. Furthermore, people are becoming more aware of the available treatment alternatives, which is leading to a higher adoption rate. Furthermore, advances in medical research are helping to produce new and improved antipsoriatic medicines, giving promise for better management of this disorder.

What Are The Key Challenges Encountered By The Global Antipsoriatics Market?

The high cost of pharmaceuticals is a significant impediment, as it can prevent certain patients from receiving therapy. Furthermore, patient adherence and satisfaction may be impacted by the possible side effects of antipsoriatic medications. To maintain best patient outcomes, it is critical to identify strategies to make therapies more cheap while minimizing the risk of side effects.

What Opportunities For Growth Exist In The Global Antipsoriatics Market?

The antipsoriatics market offers numerous chances. Innovative medicines show considerable promise for improving treatment outcomes and increasing the quality of life for those living with psoriasis. Furthermore, there is substantial development potential in emerging economies, where psoriasis awareness is growing and healthcare infrastructure is becoming more important. By increasing the market in these areas, more people will have access to effective antipsoriatic medications, resulting in better disease management and patient outcomes.

Market Drivers

The global Antipsoriatics Market is driven by several factors. The following are the key drivers of the global Antipsoriatics Market:

Increasing Prevalence of Psorasis

The rising prevalence of psoriasis is one of the primary drivers of the Antipsoriatics Market. Psoriasis is a chronic autoimmune skin illness that affects a large number of people around the world. Due to a number of causes, including genetic predisposition, environmental triggers, and alterations in lifestyle, psoriasis is becoming increasingly widespread. As more people are diagnosed with psoriasis, the demand for effective treatment alternatives, such as antipsoriatic medicines, grows. Because of the growing prevalence, there is a larger patient pool, which drives the market for antipsoriatics. Pharmaceutical firms are investing in R&D to develop novel, targeted medications to address the unique requirements of people with psoriasis.

Furthermore, advances in medical technology and increased awareness of psoriasis have resulted in earlier detection and diagnosis, adding to the growing demand for antipsoriatic therapy. The rising prevalence of psoriasis emphasizes the relevance of the Antipsoriatics Market in delivering solutions and enhancing the quality of life for those suffering from the disease.

Market Restraints

The global Antipsoriatics Market faces some challenges that may hinder its growth. These include the following:

Potential Side Effects of Antipsoriatic

While these drugs are intended to provide relief from psoriasis symptoms, they may also have side effects. Skin irritation, dryness, redness, and itching at the application site are common side effects of antipsoriatics. Systemic drugs may cause more severe adverse effects in some circumstances, such as liver damage, an increased risk of infection, or gastrointestinal difficulties. These potential adverse effects can be concerning for both patients and healthcare providers since they may have an influence on treatment adherence and patient satisfaction.

High Cost of Medications

Antipsoriatic drugs can be highly costly, especially branded pharmaceuticals that have undergone substantial research and development. This high cost might place a financial strain on patients, limiting their access to vital therapies. While generic drugs are less expensive, some patients may still require specialized branded prescriptions for psoriasis management. Efforts are being made to solve this issue through the development of more cost-effective treatment choices and the availability of insurance coverage or patient assistance programs. However, the high cost of drugs remains a substantial barrier to enabling fair access to effective antipsoriatic therapy for all psoriasis patients.

Opportunities

The global Antipsoriatics Market offers significant growth opportunities. These include the following:

Development Of Innovative Therapies

the development of novel medicines represents a substantial opportunity. With continued research and developments in medical technology, there is an increasing possibility of introducing new and improved psoriasis therapies. These novel therapies strive to deliver more tailored and effective solutions that fit patients’ individual needs. Novel biologic medicines, small molecule inhibitors, or gene therapies may be among them. By investing in the creation of these breakthrough medicines, pharmaceutical corporations may enhance patient outcomes while obtaining a commercial edge. The chance to develop novel medicines gives those living with psoriasis hope for better control and alleviation.

Competitive Landscape

Key Players

The global Antipsoriatics Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

Pfizer Inc.
AbbVie Inc.
Novartis AG
Evelo Biosciences, Inc
Amgen Inc.
Eli Lilly and Company
Evelo Biosciences, Inc.
LEO Pharma A/S
Merck & Co., Inc.
Johnson & Johnson Services, Inc.

These organizations prioritize product innovation, Disease Area expansion, and mergers and acquisitions to stay competitive.

The global Antipsoriatics Market’s key players continually seek to stay ahead by offering new Treatment Types and developments.

In April 2019, Novartis announced that Alcon had been spun out as a distinct business organization. Alcon was traded on the SIX exchange in Switzerland and the NYSE exchange in the United States.

In April, 2023, Pfizer announced that it had relocated its global headquarters from 42nd Street in Midtown Manhattan to the Spiral at Hudson Yards.

In November 2020, Pfizer revealed that BioNTech’s COVID-19 vaccine was 90% effective in preventing symptomatic COVID-19 when tested on 43,500 patients. A week later, the efficacy was raised to 95%. The efficacy statistic, according to Akiko Iwasaki, an immunologist contacted by the New York Times, is “really a spectacular number.” Pfizer and BioNTech were the first businesses to develop and test a COVID-19 vaccine, according to the release.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Summary of Key Findings

Potential Antipsoriatic Side Effects impede Market Growth
Market segmented by Treatment Type, Biologics, Patient Age Group, Severity of Psoriasis, Delivery method, Branded Vs Generic Products and region.
IL inhibitors are the fastest growing sector in the Antipsoriatics Market
The bigger the market need for topical therapies, the greater the market demand for injectable medications.

North America is leading market growth; the market is highly competitive with key players including Pfizer Inc., AbbVie Inc., Novartis AG, Evelo Biosciences, Inc, Amgen Inc.

Future Outlook

Increasing R&D activity
Growing demand for biologic medicines
Increasing acceptance of combo medications
Expansion in emerging markets
Emphasis on tailored therapy and targeted therapies
Technological developments in drug delivery methods
Increased cooperation and partnerships in the pharmaceutical industry
Raising psoriasis awareness and education about treatment options
The incorporation of digital health solutions into illness management

Segmentation

By Treatment Type:
- Topical Agents
- Systemic Agents
By Biologics:
- TNF Inhibitors
- IL Inhibitors
- Topical Corticosteroids
By Patient Age Group:
- Adults
- Pediatrics
By Severity of Psoriasis:
- Mild to Moderate
- Moderate to Severe
By Delivery Method:
- Oral Medications
- Injectable Medications
- Topical Medications
By Branded vs. Generic Products:
- Branded Medications
- Generic Medications
By Region
- North America
  - US
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - UK.
  - Italy
  - Spain
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - South-east Asia
  - Rest of Asia Pacific
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America
- Middle East & Africa
  - GCC Countries
  - South Africa
  - Rest of Middle East and Africa

Adjacent Markets

In the Antipsoriatics Market, there are several adjacent markets which has high revenue growth opportunities. The key adjacent markets for Antipsoriatics Market-

1. Preface

1.1. Report Description

1.1.1. Purpose of the Report

1.1.2. Target Audience

1.1.3. USP and Key Offerings

1.2. Research Scope

1.3. Market Introduction

2. Executive Summary

2.1. Market Snapshot: Global Antipsoriatics Market

2.1.1. Global Antipsoriatics Market, By Treatment Type

2.1.2. Global Antipsoriatics Market, By Biologics

2.1.3. Global Antipsoriatics Market, By Patient Age Group

2.1.4. Global Antipsoriatics Market, By Severity of Psoriasis

2.1.5. Global Antipsoriatics Market, By Delivery Method

2.1.6. Global Antipsoriatics Market, By Branded vs. Generic Products

2.1.7. Global Antipsoriatics Market, By Region

2.2. Insights from Primary Respondents

3. Market Dynamics & Factors Analysis

3.1. Introduction

3.1.1. Global Antipsoriatics Market Value, 2017-2030, (US$ Mn)

3.1.2. Y-o-Y Growth Trend Analysis

3.2. Market Dynamics

3.2.1. Antipsoriatics Market Drivers

3.2.2. AntipsoriaticsMarket Restraints

3.2.3. AntipsoriaticsMarket Opportunities

3.2.4. Major Antipsoriatics Industry Challenges

3.3. Growth and Development Patterns

3.4. Investment Feasibility Analysis

3.5. Market Opportunity Analysis

3.5.1. Treatment Type

3.5.2. Biologics

3.5.3. Patient Age Group

3.5.4. Severity of Psoriasis

3.5.5. Delivery Method

3.5.6. Branded vs. Generic Products

3.5.7. Geography

4. Market Competitive Landscape Analysis

4.1. Company Market Share Analysis, 2022

4.1.1. Global Antipsoriatics Market: Company Market Share, Value 2022

4.1.2. Global Antipsoriatics Market: Top 6 Company Market Share, Value 2022

4.1.3. Global Antipsoriatics Market: Top 3 Company Market Share, Value 2022

4.2. Global Antipsoriatics Market: Company Revenue Share Analysis, 2022

4.3. Company Assessment Metrics, 2022

4.3.1. Stars

4.3.2. Emerging Leaders

4.3.3. Pervasive Players

4.3.4. Participants

4.4. Startups/ SMEs Assessment Metrics, 2022

4.4.1. Progressive Companies

4.4.2. Responsive Companies

4.4.3. Dynamic Companies

4.4.4. Starting Blocks

4.5. Strategic Development

4.5.1. Acquisition and Mergers

4.5.2. New Product Launch

4.5.3. Regional Expansion

4.5.4. Partnerships

4.6. Key Player Product Matrix

4.7. Potential for New Players in the Global Antipsoriatics Market

5. Premium Insights

5.1. STAR (Situation, Task, Action, Results) Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Threat of New Entrants

5.2.2. Bargaining Power of Buyers/Consumers

5.2.3. Bargaining Power of Suppliers

5.2.4. Threat of Substitute Types

5.2.5. Intensity of Competitive Rivalry

5.3. PESTEL Analysis

5.3.1. Political Factors

5.3.2. Economic Factors

5.3.3. Social Factors

5.3.4. Technological Factors

5.3.5. Environmental Factors

5.3.6. Legal Factors

5.4. Key Market Trends

5.4.1. Demand Side Trends

5.4.2. Supply Side Trends

5.5. Value Chain Analysis

5.6. Technology Analysis

5.6.1. Research and development in the global market

5.6.2. Patent Analysis

5.6.3. Emerging technologies and their potential disruption to the market

5.7. Consumer Behaviour Analysis

5.7.1. Consumer Preferences and Expectations

5.7.2. Factors Influencing Consumer Buying Decisions

5.7.2.1. North America

5.7.2.2. Europe

5.7.2.3. Asia Pacific

5.7.2.4. Latin America

5.7.2.5. Middle East and Africa

5.7.3. Consumer Pain Points

5.8. Analysis and Recommendations

5.9. Adjacent Market Analysis

6. Market Positioning of Key Players, 2022

6.1. Company market share of key players, 2022

6.2. Competitive Benchmarking

6.3. Market Positioning of Key Vendors

6.4. Geographical Presence Analysis

6.5. Major Strategies Adopted by Key Players

6.5.1. Key Strategies Analysis

6.5.2. Mergers and Acquisitions

6.5.3. Partnerships

6.5.4. Product Launch

6.5.5. Geographical Expansion

6.5.6. Others

7. Impact Analysis of COVID 19 and Russia – Ukraine War on Antipsoriatics Market

7.1. Ukraine-Russia War Impact

7.1.1. Uncertainty and Economic Instability

7.1.2. Supply chain disruptions

7.1.3. Regional market shifts

7.1.4. Shift in government priorities

7.2. COVID-19 Impact Analysis

7.2.1. Supply Chain Disruptions

7.2.2. Demand Fluctuations

7.2.3. Shift in Product Mix

7.2.4. Reduced Industrial Activity

7.2.5. Regional Impact Analysis

7.2.5.1. North America

7.2.5.2. Europe

7.2.5.3. Asia Pacific

7.2.5.4. Latin America

7.2.5.5. Middle East and Africa

8. Global Antipsoriatics Market, By Treatment Type

8.1. Global Antipsoriatics Market Overview, by Treatment Type

8.1.1. Global Antipsoriatics Market Revenue Share, By Treatment Type, 2022 Vs 2030 (in %)

8.2. Topical Agents

8.2.1. Global Antipsoriatics Market, By TOPICAL AGENTS, By Region, 2017-2030 (US$ Mn)

8.2.2. Market Dynamics for TOPICAL AGENTS

8.2.2.1. Drivers

8.2.2.2. Restraints

8.2.2.3. Opportunities

8.2.2.4. Trends

8.3. Systemic Agents

8.3.1. Global Antipsoriatics Market, By Systemic Agents, By Region, 2017-2030 (US$ Mn)

8.3.2. Market Dynamics for Systemic Agents

8.3.2.1. Drivers

8.3.2.2. Restraints

8.3.2.3. Opportunities

8.3.2.4. Trends

9. Global Antipsoriatics Market, By Biologics

9.1. Global Antipsoriatics Market Overview, by Biologics

9.1.1. Global Antipsoriatics Market Revenue Share, By Biologics, 2022 Vs 2030 (in %)

9.2. TNF Inhibitors

9.2.1. Global Antipsoriatics Market, By TNF Inhibitors, By Region, 2017-2030 (US$ Mn)

9.2.2. Market Dynamics for TNF Inhibitors

9.2.2.1. Drivers

9.2.2.2. Restraints

9.2.2.3. Opportunities

9.2.2.4. Trends

9.3. IL Inhibitors

9.3.1. Global Antipsoriatics Market, By IL Inhibitors, By Region, 2017-2030 (US$ Mn)

9.3.2. Market Dynamics for IL Inhibitors

9.3.2.1. Drivers

9.3.2.2. Restraints

9.3.2.3. Opportunities

9.3.2.4. Trends

9.4. Topical Corticosteroids

9.4.1. Global Antipsoriatics Market, By Topical Corticosteroids, By Region, 2017-2030 (US$ Mn)

9.4.2. Market Dynamics for Topical Corticosteroids

9.4.2.1. Drivers

9.4.2.2. Restraints

9.4.2.3. Opportunities

9.4.2.4. Trends

10. Global Antipsoriatics Market, By Patient Age Group

10.1. Global Antipsoriatics Market Overview, by Patient Age Group

10.1.1. Global Antipsoriatics Market Revenue Share, By Patient Age Group, 2022 Vs 2030 (in %)

10.2. Adults

10.2.1. Global Antipsoriatics Market, By Adults, By Region, 2017-2030 (US$ Mn)

10.2.2. Market Dynamics for Adults

10.2.2.1. Drivers

10.2.2.2. Restraints

10.2.2.3. Opportunities

10.2.2.4. Trends

10.3. Pediatrics

10.3.1. Global Antipsoriatics Market, By Pediatrics, By Region, 2017-2030 (US$ Mn)

10.3.2. Market Dynamics for Pediatrics

10.3.2.1. Drivers

10.3.2.2. Restraints

10.3.2.3. Opportunities

10.3.2.4. Trends

11. Global Antipsoriatics Market, By Severity of Psoriasis

11.1. Global Antipsoriatics Market Overview, by Severity of Psoriasis

11.1.1. Global Antipsoriatics Market Revenue Share, By Severity of Psoriasis, 2022 Vs 2030 (in %)

11.2. Mild to Moderate

11.2.1. Global Antipsoriatics Market, By Mild to Moderate, By Region, 2017-2030 (US$ Mn)

11.2.2. Market Dynamics for Mild to Moderate

11.2.2.1. Drivers

11.2.2.2. Restraints

11.2.2.3. Opportunities

11.2.2.4. Trends

11.3. Moderate to Severe

11.3.1. Global Antipsoriatics Market, By Moderate to Severe, By Region, 2017-2030 (US$ Mn)

11.3.2. Market Dynamics for Moderate to Severe

11.3.2.1. Drivers

11.3.2.2. Restraints

11.3.2.3. Opportunities

11.3.2.4. Trends

12. Global Antipsoriatics Market, By Delivery Method

12.1. Global Antipsoriatics Market Overview, by Delivery Method

12.1.1. Global Antipsoriatics Market Revenue Share, By Delivery Method, 2022 Vs 2030 (in %)

12.2. Oral Medications

12.2.1. Global Antipsoriatics Market, By Oral Medications, By Region, 2017-2030 (US$ Mn)

12.2.2. Market Dynamics for Oral Medications

12.2.2.1. Drivers

12.2.2.2. Restraints

12.2.2.3. Opportunities

12.2.2.4. Trends

12.3. Injectable Medications

12.3.1. Global Antipsoriatics Market, By Injectable Medications, By Region, 2017-2030 (US$ Mn)

12.3.2. Market Dynamics for Injectable Medications

12.3.2.1. Drivers

12.3.2.2. Restraints

12.3.2.3. Opportunities

12.3.2.4. Trends

13. Global Antipsoriatics Market, By Branded vs. Generic Products

13.1. Global Antipsoriatics Market Overview, by Branded vs. Generic Products

13.1.1. Global Antipsoriatics Market Revenue Share, By Branded vs. Generic Products, 2022 Vs 2030 (in %)

13.2. Branded Medications

13.2.1. Global Antipsoriatics Market, By Branded Medications, By Region, 2017-2030 (US$ Mn)

13.2.2. Market Dynamics for Branded Medications

13.2.2.1. Drivers

13.2.2.2. Restraints

13.2.2.3. Opportunities

13.2.2.4. Trends

13.3. Generic Medications

13.3.1. Global Antipsoriatics Market, By Generic Medications, By Region, 2017-2030 (US$ Mn)

13.3.2. Market Dynamics for Generic Medications

13.3.2.1. Drivers

13.3.2.2. Restraints

13.3.2.3. Opportunities

13.3.2.4. Trends

14. Global Antipsoriatics Market, By Region

14.1. Global Antipsoriatics Market Overview, by Region

14.1.1. Global Antipsoriatics Market, By Region, 2022 vs 2030 (in%)

14.2. Treatment Type

14.2.1. Global Antipsoriatics Market, By Treatment Type, 2017-2030 (US$ Mn)

14.3. Biologics

14.3.1. Global Antipsoriatics Market, By Biologics, 2017-2030 (US$ Mn)

14.4. Patient Age Group

14.4.1. Global Antipsoriatics Market, By Patient Age Group, 2017-2030 (US$ Mn)

14.5. Severity of Psoriasis

14.5.1. Global Antipsoriatics Market, By Severity of Psoriasis, 2017-2030 (US$ Mn)

14.6. Delivery Method

14.6.1. Global Antipsoriatics Market, By Delivery Method, 2017-2030 (US$ Mn)

14.7. Branded vs. Generic Products

14.7.1. Global Antipsoriatics Market, By Branded vs. Generic Products, 2017-2030 (US$ Mn)

15. North America Antipsoriatics Market Analysis

15.1. Overview

15.1.1. Market Dynamics for North America

15.1.1.1. Drivers

15.1.1.2. Restraints

15.1.1.3. Opportunities

15.1.1.4. Trends

15.2. North America Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

15.2.1. Overview

15.2.2. SRC Analysis

15.3. North America Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

15.3.1. Overview

15.3.2. SRC Analysis

15.4. North America Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

15.4.1. Overview

15.4.2. SRC Analysis

15.5. North America Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

15.5.1. Overview

15.5.2. SRC Analysis

15.6. North America Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

15.6.1. Overview

15.6.2. SRC Analysis

15.7. North America Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

15.7.1. Overview

15.7.2. SRC Analysis

15.8. North America Antipsoriatics Market, by Country, 2017-2030(US$ Mn)

15.8.1. North America Antipsoriatics Market, by Country, 2022 Vs 2030 (in%)

15.8.2. U.S.

15.8.3. Canada

15.8.4. Mexico

16. Europe Antipsoriatics Market Analysis

16.1. Overview

16.1.1. Market Dynamics for North America

16.1.1.1. Drivers

16.1.1.2. Restraints

16.1.1.3. Opportunities

16.1.1.4. Trends

16.2. Europe Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

16.2.1. Overview

16.2.2. SRC Analysis

16.3. Europe Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

16.3.1. Overview

16.3.2. SRC Analysis

16.4. Europe Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

16.4.1. Overview

16.4.2. SRC Analysis

16.5. Europe Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

16.5.1. Overview

16.5.2. SRC Analysis

16.6. Europe Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

16.6.1. Overview

16.6.2. SRC Analysis

16.7. Europe Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

16.7.1. Overview

16.7.2. SRC Analysis

16.8. Europe Antipsoriatics Market, by Country, 2017-2030 (US$ Mn)

16.8.1. Europe Antipsoriatics Market, by Country, 2022 Vs 2030 (in%)

16.8.2. UK

16.8.3. France

16.8.4. Germany

16.8.5. Italy

16.8.6. Spain

16.8.7. Benelux

16.8.8. Russia

16.8.9. Rest of Europe

17. Asia Pacific Antipsoriatics Market Analysis

17.1. Overview

17.1.1. Market Dynamics for North America

17.1.1.1. Drivers

17.1.1.2. Restraints

17.1.1.3. Opportunities

17.1.1.4. Trends

17.2. Asia Pacific Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

17.2.1. Overview

17.2.2. SRC Analysis

17.3. Asia Pacific Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

17.3.1. Overview

17.3.2. SRC Analysis

17.4. Asia Pacific Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

17.4.1. Overview

17.4.2. SRC Analysis

17.5. Asia Pacific Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

17.5.1. Overview

17.5.2. SRC Analysis

17.6. Asia Pacific Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

17.6.1. Overview

17.6.2. SRC Analysis

17.7. Asia Pacific Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

17.7.1. Overview

17.7.2. SRC Analysis

17.8. Asia Pacific Antipsoriatics Market, by Country, 2017-2030 (US$ Mn)

17.8.1. Asia Pacific Antipsoriatics Market, by Country, 2022 Vs 2030 (in%)

17.8.2. China

17.8.3. Japan

17.8.4. India

17.8.5. South Korea

17.8.6. South East Asia

17.8.7. Rest of Asia Pacific

18. Latin America Antipsoriatics Market Analysis

18.1. Overview

18.1.1. Market Dynamics for North America

18.1.1.1. Drivers

18.1.1.2. Restraints

18.1.1.3. Opportunities

18.1.1.4. Trends

18.2. Latin America Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

18.2.1. Overview

18.2.2. SRC Analysis

18.3. Latin America Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

18.3.1. Overview

18.3.2. SRC Analysis

18.4. Latin America Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

18.4.1. Overview

18.4.2. SRC Analysis

18.5. Latin America Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

18.5.1. Overview

18.5.2. SRC Analysis

18.6. Latin America Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

18.6.1. Overview

18.6.2. SRC Analysis

18.7. Latin America Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

18.7.1. Overview

18.7.2. SRC Analysis

18.8. Latin America Antipsoriatics Market, by Country, 2017-2030 (US$ Mn)

18.8.1. Latin America Antipsoriatics Market, by Country, 2022 Vs 2030 (in%)

18.8.2. Brazil

18.8.3. Argentina

18.8.4. Rest of Latin America

19. Middle East Antipsoriatics Market Analysis

19.1. Overview

19.1.1. Market Dynamics for North America

19.1.1.1. Drivers

19.1.1.2. Restraints

19.1.1.3. Opportunities

19.1.1.4. Trends

19.2. Middle East Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

19.2.1. Overview

19.2.2. SRC Analysis

19.3. Middle East Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

19.3.1. Overview

19.3.2. SRC Analysis

19.4. Middle East Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

19.4.1. Overview

19.4.2. SRC Analysis

19.5. Middle East Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

19.5.1. Overview

19.5.2. SRC Analysis

19.6. Middle East Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

19.6.1. Overview

19.6.2. SRC Analysis

19.7. Middle East Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

19.7.1. Overview

19.7.2. SRC Analysis

19.8. Middle East Antipsoriatics Market, by Country, 2017-2030 (US$ Mn)

19.8.1. Middle East Antipsoriatics Market, by Country, 2022 Vs 2030 (in%)

19.8.2. UAE

19.8.3. Saudi Arabia

19.8.4. Rest of Middle East

20. Africa Antipsoriatics Market Analysis

20.1. Overview

20.1.1. Market Dynamics for North America

20.1.1.1. Drivers

20.1.1.2. Restraints

20.1.1.3. Opportunities

20.1.1.4. Trends

20.2. Africa Antipsoriatics Market, by Treatment Type, 2017-2030(US$ Mn)

20.2.1. Overview

20.2.2. SRC Analysis

20.3. Africa Antipsoriatics Market, by Biologics, 2017-2030(US$ Mn)

20.3.1. Overview

20.3.2. SRC Analysis

20.4. Africa Antipsoriatics Market, by Patient Age Group, 2017-2030(US$ Mn)

20.4.1. Overview

20.4.2. SRC Analysis

20.5. Africa Antipsoriatics Market, by Severity of Psoriasis, 2017-2030(US$ Mn)

20.5.1. Overview

20.5.2. SRC Analysis

20.6. Africa Antipsoriatics Market, by Delivery Method, 2017-2030(US$ Mn)

20.6.1. Overview

20.6.2. SRC Analysis

20.7. Africa Antipsoriatics Market, by Branded vs. Generic Products, 2017-2030(US$ Mn)

20.7.1. Overview

20.7.2. SRC Analysis

20.8. Africa Antipsoriatics Market, by Country, 2017-2030 (US$ Mn)

20.8.1. Middle EastAntipsoriatics Market, by Country, 2022 Vs 2030 (in%)

20.8.2. South Africa

20.8.3. Egypt

20.8.4. Rest of Africa

21. Company Profiles

21.1. Pfizer Inc.

21.1.1. Company Overview

21.1.2. Products/Services Portfolio

21.1.3. Geographical Presence

21.1.4. SWOT Analysis

21.1.5. Financial Summary

21.1.5.1. Market Revenue and Net Profit (2019-2022)

21.1.5.2. Business Segment Revenue Analysis

21.1.5.3. Geographical Revenue Analysis

21.2. AbbVie Inc.

21.3. Novartis AG

21.4. Evelo Biosciences, Inc

21.5. Amgen Inc.

21.6. Eli Lilly and Company

21.7. Evelo Biosciences, Inc.

21.8. LEO Pharma A/S

21.9. Merck & Co., Inc.

21.10. Johnson & Johnson Services, Inc.

22. Research Methodology

22.1. Research Methodology

22.2. Phase I – Secondary Research

22.3. Phase II – Data Modelling

22.3.1. Company Share Analysis Model

22.3.2. Revenue Based Modelling

22.4. Phase III – Primary Research

22.5. Research Limitations

22.5.1. Assumptions

List of Figures

FIG. 1 Global Antipsoriatics Market: Research Methodology

FIG. 2 Market Size Estimation – Top Down & Bottom up Approach

FIG. 3 Global Antipsoriatics Market Segmentation

FIG. 4 Global Antipsoriatics Market, by Treatment Type, 2022 (US$ Mn)

FIG. 5 Global Antipsoriatics Market, by Biologics, 2022 (US$ Mn)

FIG. 6 Global Antipsoriatics Market, by Patient Age Group, 2022 (US$ Mn)

FIG. 7 Global Antipsoriatics Market, by Severity of Psoriasis, 2022 (US$ Mn)

FIG. 8 Global Antipsoriatics Market, by Delivery Method, 2022 (US$ Mn)

FIG. 9 Global Antipsoriatics Market, by Branded vs. Generic Products, 2022 (US$ Mn)

FIG. 10 Global Antipsoriatics Market, by Geography, 2022 (US$ Mn)

FIG. 11 Attractive Investment Proposition, by Treatment Type, 2022

FIG. 12 Attractive Investment Proposition, by Biologics, 2022

FIG. 13 Attractive Investment Proposition, by Patient Age Group, 2022

FIG. 14 Attractive Investment Proposition, by Severity of Psoriasis, 2022

FIG. 15 Attractive Investment Proposition, by Delivery Method, 2022

FIG. 16 Attractive Investment Proposition, by Branded vs. Generic Products, 2022

FIG. 17 Attractive Investment Proposition, by Geography, 2022

FIG. 18 Global Market Share Analysis of Key Antipsoriatics Market Manufacturers, 2022

FIG. 19 Global Market Positioning of Key Antipsoriatics Market Manufacturers, 2022

FIG. 20 Global Antipsoriatics Market Value Contribution, By Treatment Type, 2022 & 2030 (Value %)

FIG. 21 Global Antipsoriatics Market, by TOPICAL AGENTS, Value, 2017-2030 (US$ Mn)

FIG. 22 Global Antipsoriatics Market, by Systemic Agents, Value, 2017-2030 (US$ Mn)

FIG. 23 Global Antipsoriatics Market, by Sun Protection Products, Value, 2017-2030 (US$ Mn)

FIG. 24 Global Antipsoriatics Market, by TNF Inhibitors Products, Value, 2017-2030 (US$ Mn)

FIG. 25 Global Antipsoriatics Market Value Contribution, By Biologics, 2022 & 2030 (Value %)

FIG. 26 Global Antipsoriatics Market, by TNF Inhibitors, Value, 2017-2030 (US$ Mn)

FIG. 27 Global Antipsoriatics Market, by IL Inhibitors, Value, 2017-2030 (US$ Mn)

FIG. 28 Global Antipsoriatics Market, by Topical Corticosteroids, Value, 2017-2030 (US$ Mn)

FIG. 29 Global Antipsoriatics Market Value Contribution, By Patient Age Group, 2022 & 2030 (Value %)

FIG. 30 Global Antipsoriatics Market, by Adults, Value, 2017-2030 (US$ Mn)

FIG. 31 Global Antipsoriatics Market, by Pediatrics, Value, 2017-2030 (US$ Mn)

FIG. 32 Global Antipsoriatics Market Value Contribution, By Severity of Psoriasis, 2022 & 2030 (Value %)

FIG. 33 Global Antipsoriatics Market, by Mild to Moderate, Value, 2017-2030 (US$ Mn)

FIG. 34 Global Antipsoriatics Market, by Moderate to Severe, Value, 2017-2030 (US$ Mn)

FIG. 35 Global Antipsoriatics Market Value Contribution, By Delivery Method, 2022 & 2030 (Value %)

FIG. 36 Global Antipsoriatics Market, by Oral Medications, Value, 2017-2030 (US$ Mn)

FIG. 37 Global Antipsoriatics Market, by Injectable Medications, Value, 2017-2030 (US$ Mn)

FIG. 38 Global Antipsoriatics Market Value Contribution, By Branded vs. Generic Products, 2022 & 2030 (Value %)

FIG. 39 Global Antipsoriatics Market, by Branded Medications, Value, 2017-2030 (US$ Mn)

FIG. 40 Global Antipsoriatics Market, by Generic Medications, Value, 2017-2030 (US$ Mn)

FIG. 41 Global Antipsoriatics Market, by Gum Health, Value, 2017-2030 (US$ Mn)

FIG. 42 North America Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 43 U.S. Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 44 Canada Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 45 Mexico Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 46 Europe Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 47 Germany Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 48 France Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 49 U.K. Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 50 Italy Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 51 Spain Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 52 Benelux Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 53 Russia Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 54 Rest of Europe Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 55 Asia Pacific Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 56 China Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 57 Japan Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 58 India Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 59 South Korea Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 60 South-East Asia Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 61 Rest of Asia Pacific Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 62 Latin America Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 63 Brazil Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 64 Argentina Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 65 Rest of Latin America Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 66 Middle East Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 67 UAE Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 68 Saudi Arabia Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 69 Rest of Middle East Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 70 Africa Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 71 South Africa Antipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 72 Egyp tAntipsoriatics Market, 2017-2030 (US$ Mn)

FIG. 73 Rest of Africa Antipsoriatics Market, 2017-2030 (US$ Mn)

List of Tables

TABLE 1 Market Snapshot: Global Antipsoriatics Market

TABLE 2 Global Antipsoriatics Market: Market Drivers Impact Analysis

TABLE 3 Global Antipsoriatics Market: Market Restraints Impact Analysis

TABLE 4 Global Antipsoriatics Market, by Competitive Benchmarking, 2022

TABLE 5 Global Antipsoriatics Market, by Geographical Presence Analysis, 2022

TABLE 6 Global Antipsoriatics Market, by Key Strategies Analysis, 2022

TABLE 7 Global Antipsoriatics Market, by TOPICAL AGENTS, By Region, 2017-2022 (US$ Mn)

TABLE 8 Global Antipsoriatics Market, by TOPICAL AGENTS, By Region, 2023-2030 (US$ Mn)

TABLE 9 Global Antipsoriatics Market, by Systemic Agents, By Region, 2017-2022 (US$ Mn)

TABLE 10 Global Antipsoriatics Market, by Systemic Agents, By Region, 2023-2030 (US$ Mn)

TABLE 11 Global Antipsoriatics Market, by Sun Protection Products, By Region, 2017-2022 (US$ Mn)

TABLE 12 Global Antipsoriatics Market, by Sun Protection Products, By Region, 2023-2030 (US$ Mn)

TABLE 13 Global Antipsoriatics Market, by TNF Inhibitors Products, By Region, 2017-2022 (US$ Mn)

TABLE 14 Global Antipsoriatics Market, by TNF Inhibitors Products, By Region, 2023-2030 (US$ Mn)

TABLE 15 Global Antipsoriatics Market, by TNF Inhibitors, By Region, 2017-2022 (US$ Mn)

TABLE 16 Global Antipsoriatics Market, by TNF Inhibitors, By Region, 2023-2030 (US$ Mn)

TABLE 17 Global Antipsoriatics Market, by IL Inhibitors, By Region, 2017-2022 (US$ Mn)

TABLE 18 Global Antipsoriatics Market, by IL Inhibitors, By Region, 2023-2030 (US$ Mn)

TABLE 19 Global Antipsoriatics Market, by Topical Corticosteroids, By Region, 2017-2022 (US$ Mn)

TABLE 20 Global Antipsoriatics Market, by Topical Corticosteroids, By Region, 2023-2030 (US$ Mn)

TABLE 21 Global Antipsoriatics Market, by Adults, By Region, 2017-2022 (US$ Mn)

TABLE 22 Global Antipsoriatics Market, by Adults, By Region, 2023-2030 (US$ Mn)

TABLE 23 Global Antipsoriatics Market, by Pediatrics, By Region, 2017-2022 (US$ Mn)

TABLE 24 Global Antipsoriatics Market, by Pediatrics, By Region, 2023-2030 (US$ Mn)

TABLE 25 Global Antipsoriatics Market, by Mild to Moderate, By Region, 2017-2022 (US$ Mn)

TABLE 26 Global Antipsoriatics Market, by Mild to Moderate, By Region, 2023-2030 (US$ Mn)

TABLE 27 Global Antipsoriatics Market, by Moderate to Severe, By Region, 2017-2022 (US$ Mn)

TABLE 28 Global Antipsoriatics Market, by Moderate to Severe, By Region, 2023-2030 (US$ Mn)

TABLE 29 Global Antipsoriatics Market, by Oral Medications, By Region, 2023-2030 (US$ Mn)

TABLE 30 Global Antipsoriatics Market, by Oral Medications, By Region, 2017-2022 (US$ Mn)

TABLE 31 Global Antipsoriatics Market, by Injectable Medications, By Region, 2023-2030 (US$ Mn)

TABLE 32 Global Antipsoriatics Market, by Injectable Medications, By Region, 2017-2022 (US$ Mn)

TABLE 33 Global Antipsoriatics Market, by Branded Medications, By Region, 2017-2022 (US$ Mn)

TABLE 34 Global Antipsoriatics Market, by Branded Medications, By Region, 2023-2030 (US$ Mn)

TABLE 35 Global Antipsoriatics Market, by Generic Medications, By Region, 2017-2022 (US$ Mn)

TABLE 36 Global Antipsoriatics Market, by Generic Medications, By Region, 2023-2030 (US$ Mn)

TABLE 37 Global Antipsoriatics Market, by Gum Health, By Region, 2017-2022 (US$ Mn)

TABLE 38 Global Antipsoriatics Market, by Gum Health, By Region, 2023-2030 (US$ Mn)

TABLE 39 Global Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 40 Global Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 41 Global Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 42 Global Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 43 Global Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 44 Global Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 45 Global Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 46 Global Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 47 Global Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 48 Global Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 49 Global Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 50 Global Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 51 Global Antipsoriatics Market, by Region, 2017-2022 (US$ Mn)

TABLE 52 Global Antipsoriatics Market, by Region, 2023-2030 (US$ Mn)

TABLE 53 North America Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 54 North America Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 55 North America Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 56 North America Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 57 North America Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 58 North America Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 59 North America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 60 North America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 61 North America Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 62 North America Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 63 North America Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 64 North America Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 65 North America Antipsoriatics Market, by Country, 2017-2022 (US$ Mn)

TABLE 66 North America Antipsoriatics Market, by Country, 2023-2030 (US$ Mn)

TABLE 67 United States Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 68 United States Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 69 United States Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 70 United States Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 71 United States Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 72 United States Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 73 United States Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 74 United States Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 75 United States Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 76 United States Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 77 United States Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 78 United States Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 79 Canada Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 80 Canada Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 81 Canada Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 82 Canada Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 83 Canada Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 84 Canada Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 85 Canada Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 86 Canada Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 87 Canada Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 88 Canada Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 89 Canada Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 90 Canada Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 91 Mexico Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 92 Mexico Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 93 Mexico Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 94 Mexico Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 95 Mexico Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 96 Mexico Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 97 Mexico Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 98 Mexico Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 99 Mexico Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 100 Mexico Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 101 Mexico Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 102 Mexico Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 103 Europe Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 104 Europe Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 105 Europe Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 106 Europe Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 107 Europe Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 108 Europe Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 109 Europe Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 110 Europe Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 111 Europe Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 112 Europe Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 113 Europe Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 114 Europe Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 115 Europe Antipsoriatics Market, by Country, 2017-2022 (US$ Mn)

TABLE 116 Europe Antipsoriatics Market, by Country, 2023-2030 (US$ Mn)

TABLE 117 Germany Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 118 Germany Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 119 Germany Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 120 Germany Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 121 Germany Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 122 Germany Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 123 Germany Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 124 Germany Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 125 Germany Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 126 Germany Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 127 Germany Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 128 Germany Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 129 France Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 130 France Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 131 France Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 132 France Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 133 France Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 134 France Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 135 France Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 136 France Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 137 France Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 138 France Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 139 France Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 140 France Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 141 United Kingdom Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 142 United Kingdom Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 143 United Kingdom Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 144 United Kingdom Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 145 United Kingdom Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 146 United Kingdom Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 147 United Kingdom Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 148 United Kingdom Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 149 United Kingdom Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 150 United Kingdom Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 151 United Kingdom Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 152 United Kingdom Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 153 Italy Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 154 Italy Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 155 Italy Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 156 Italy Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 157 Italy Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 158 Italy Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 159 Italy Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 160 Italy Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 161 Italy Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 162 Italy Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 163 Italy Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 164 Italy Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 165 Spain Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 166 Spain Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 167 Spain Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 168 Spain Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 169 Spain Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 170 Spain Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 171 Spain Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 172 Spain Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 173 Spain Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 174 Spain Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 175 Spain Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 176 Spain Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 177 Benelux Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 178 Benelux Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 179 Benelux Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 180 Benelux Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 181 Benelux Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 182 Benelux Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 183 Benelux Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 184 Benelux Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 185 Benelux Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 186 Benelux Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 187 Benelux Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 188 Benelux Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 189 Russia Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 190 Russia Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 191 Russia Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 192 Russia Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 193 Russia Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 194 Russia Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 195 Russia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 196 Russia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 197 Russia Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 198 Russia Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 199 Russia Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 200 Russia Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 201 Rest of Europe Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 202 Rest of Europe Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 203 Rest of Europe Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 204 Rest of Europe Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 205 Rest of Europe Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 206 Rest of Europe Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 207 Rest of Europe Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 208 Rest of Europe Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 209 Rest of Europe Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 210 Rest of Europe Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 211 Rest of Europe Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 212 Rest of Europe Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 213 Asia Pacific Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 214 Asia Pacific Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 215 Asia Pacific Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 216 Asia Pacific Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 217 Asia Pacific Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 218 Asia Pacific Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 219 Asia Pacific Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 220 Asia Pacific Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 221 Asia Pacific Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 222 Asia Pacific Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 223 Asia Pacific Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 224 Asia Pacific Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 225 China Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 226 China Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 227 China Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 228 China Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 229 China Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 230 China Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 231 China Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 232 China Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 233 China Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 234 China Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 235 China Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 236 China Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 237 Japan Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 238 Japan Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 239 Japan Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 240 Japan Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 241 Japan Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 242 Japan Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 243 Japan Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 244 Japan Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 245 Japan Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 246 Japan Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 247 Japan Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 248 Japan Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 249 India Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 250 India Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 251 India Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 252 India Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 253 India Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 254 India Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 255 India Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 256 India Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 257 India Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 258 India Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 259 India Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 260 India Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 261 South Korea Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 262 South Korea Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 263 South Korea Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 264 South Korea Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 265 South Korea Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 266 South Korea Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 267 South Korea Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 268 South Korea Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 269 South Korea Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 270 South Korea Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 271 South Korea Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 272 South Korea Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 273 South-East Asia Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 274 South-East Asia Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 275 South-East Asia Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 276 South-East Asia Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 277 South-East Asia Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 278 South-East Asia Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 279 South-East Asia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 280 South-East Asia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 281 South-East Asia Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 282 South-East Asia Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 283 South-East Asia Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 284 South-East Asia Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 285 Rest of Asia Pacific Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 286 Rest of Asia Pacific Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 287 Rest of Asia Pacific Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 288 Rest of Asia Pacific Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 289 Rest of Asia Pacific Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 290 Rest of Asia Pacific Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 291 Rest of Asia Pacific Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 292 Rest of Asia Pacific Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 293 Rest of Asia Pacific Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 294 Rest of Asia Pacific Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 295 Rest of Asia Pacific Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 296 Rest of Asia Pacific Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 297 Latin America Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 298 Latin America Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 299 Latin America Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 300 Latin America Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 301 Latin America Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 302 Latin America Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 303 Latin America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 304 Latin America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 305 Latin America Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 306 Latin America Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 307 Latin America Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 308 Latin America Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 309 Brazil Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 310 Brazil Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 311 Brazil Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 312 Brazil Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 313 Brazil Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 314 Brazil Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 315 Brazil Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 316 Brazil Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 317 Brazil Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 318 Brazil Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 319 Brazil Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 320 Brazil Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 321 Argentina Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 322 Argentina Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 323 Argentina Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 324 Argentina Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 325 Argentina Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 326 Argentina Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 327 Argentina Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 328 Argentina Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 329 Argentina Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 330 Argentina Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 331 Argentina Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 332 Argentina Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 333 Rest of Latin America Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 334 Rest of Latin America Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 335 Rest of Latin America Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 336 Rest of Latin America Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 337 Rest of Latin America Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 338 Rest of Latin America Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 339 Rest of Latin America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 340 Rest of Latin America Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 341 Rest of Latin America Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 342 Rest of Latin America Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 343 Rest of Latin America Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 344 Rest of Latin America Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 345 Middle East Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 346 Middle East Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 347 Middle East Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 348 Middle East Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 349 Middle East Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 350 Middle East Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 351 Middle East Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 352 Middle East Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 353 Middle Eas tAntipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 354 Middle East Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 355 Middle East Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 356 Middle East Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 357 UAE Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 358 UAE Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 359 UAE Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 360 UAE Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 361 UAE Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 362 UAE Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 363 UAE Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 364 UAE Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 365 UAE Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 366 UAE Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 367 UAE Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 368 UAE Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 369 Saudi Arabia Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 370 Saudi Arabia Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 371 Saudi Arabia Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 372 Saudi Arabia Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 373 Saudi Arabia Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 374 Saudi Arabia Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 375 Saudi Arabia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 376 Saudi Arabia Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 377 Saudi Arabia Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 378 Saudi Arabia Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 379 Saudi Arabia Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 380 Saudi Arabia Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 381 Rest of Middle East Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 382 Rest of Middle Eas tAntipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 383 Rest of Middle East Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 384 Rest of Middle East Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 385 Rest of Middle East Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 386 Rest of Middle East Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 387 Rest of Middle East Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 388 Rest of Middle East Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 389 Rest of Middle East Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 390 Rest of Middle East Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 391 Rest of Middle East Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 392 Rest of Middle East Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 393 Africa Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 394 Africa Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 395 Africa Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 396 Africa Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 397 Africa Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 398 Africa Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 399 Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 400 Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 401 Africa Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 402 Africa Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 403 Africa Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 404 Africa Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 405 South Africa Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 406 South Africa Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 407 South Africa Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 408 South AfricaAntipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 409 South Africa Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 410 South Africa Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 411 South Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 412 South Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 413 South Africa Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 414 South Africa Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 415 South Africa Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 416 South Africa Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 417 Egypt Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 418 Egypt Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 419 Egypt Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 420 Egypt Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 421 Egypt Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 422 Egypt Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 423 Egyp tAntipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 424 Egypt Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 425 Egypt Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 426 Egyp tAntipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 427 Egyp tAntipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 428 Egypt Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

TABLE 429 Rest of Africa Antipsoriatics Market, by Treatment Type, 2017-2022 (US$ Mn)

TABLE 430 Rest of Africa Antipsoriatics Market, by Treatment Type, 2023-2030 (US$ Mn)

TABLE 431 Rest of Africa Antipsoriatics Market, by Biologics, 2017-2022 (US$ Mn)

TABLE 432 Rest of Africa Antipsoriatics Market, by Biologics, 2023-2030 (US$ Mn)

TABLE 433 Rest of Africa Antipsoriatics Market, by Patient Age Group, 2017-2022 (US$ Mn)

TABLE 434 Rest of Africa Antipsoriatics Market, by Patient Age Group, 2023-2030 (US$ Mn)

TABLE 435 Rest of Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2017-2022 (US$ Mn)

TABLE 436 Rest of Africa Antipsoriatics Market, by Severity of Psoriasis, By Region, 2023-2030 (US$ Mn)

TABLE 437 Rest of Africa Antipsoriatics Market, by Delivery Method, 2017-2022 (US$ Mn)

TABLE 438 Rest of Africa Antipsoriatics Market, by Delivery Method, 2023-2030 (US$ Mn)

TABLE 439 Rest of Africa Antipsoriatics Market, by Branded vs. Generic Products, 2017-2022 (US$ Mn)

TABLE 440 Rest of Africa Antipsoriatics Market, by Branded vs. Generic Products, 2023-2030 (US$ Mn)

Frequently Asked Questions

What is the current size of the worldwide Antipsoriatics Market?

In 2022, the global Antipsoriatics Market is expected to be worth USD XX million.

What is the predicted growth rate of the Antipsoriatics Market between 2023 and 2030?

The Antipsoriatics Market is estimated to increase at a CAGR of 8.20% between 2023 and 2030, reaching USD XX Million in 2030.

Which segment has the most market share in terms of severity of psoriasis?

The moderate to severe sector is the largest shareholder

Which treatment type segment governs the market demand for Antipsoriatics ?

Topical agents are in high demand in the market

Which Branded Vs Generic Products segment is the highest CAGR holder segment in the market over the forecast period?

The sector of generic medications has the highest CAGR

Which region is driving the Antipsoriatics industry forward?

North America will account for 45% of the Antipsoriatics Market by 2022

Who are the major players in the global Antipsoriatics Market?

The top players include Pfizer Inc., AbbVie Inc., Novartis AG, Evelo Biosciences, Inc, Amgen Inc.

What are the major market drivers of the Antipsoriatics industry?

The primary drivers of the market include the rising prevalence of psoriasis, increased awareness about possible therapies, and advancements in medical research.

What are the major market restraints of the Antipsoriatics industry?

The market’s main hurdles include high drug costs, potential side effects of antipsoriatic treatments, and limited access to treatment for some patients.

What are the major market opportunities of the Antipsoriatics industry?

The significant opportunities in the market are the development of novel medicines, the expansion of the market in emerging nations, and the focus on improving patient adherence and satisfaction.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –